The co-occurrence of the three disease entities, inflammatory bowel disease (IBD),
colorectal cancer (CRC), type 2diabetes mellitus (T2DM) along with inflammation and …

The gut microbiota is a complex community of microorganisms that inhabit the digestive
tracts of humans, living in symbiosis with the host. Dysbiosis, characterized by an imbalance …

Ulcerative colitis (UC) and Crohn's disease (CD) are two major healthcare problems of the
digestive tract, commonly known as inflammatory bowel diseases (IBD), characterized by …

Human gut microbiota contributes to host nutrition and metabolism, sustains intestinal cell
proliferation and differentiation, and modulates host immune system. The alterations in their …

Inflammatory Bowel Disease (IBD) is a term used to describe a group of complex disorders
of the gastrointestinal (GI) tract. IBDs include two main forms: Crohn's Disease (CD) and …

The pathogenesis of inflammatory bowel disease (IBD) involves an interaction between
genetically determined host susceptibility, dysregulated immune response, and the enteric …

In concern to the continuously rising global prevalence of obesity, diabetes and associated
diseases, novel preventive and therapeutic approaches are urgently required. However, to …

Recently, an unprecedented effort has been directed at understanding the interplay between
chronic inflammation and development of cancer, with the case of inflammatory bowel …

Inflammatory bowel diseases (IBDs) are a group of chronic gastrointestinal inflammatory
diseases with unknown etiology. There is a combination of well documented factors in their …

Human gut microbiota consist of numerous microorganisms, but the most abundant species
are Bacteroides and Firmicutes. Each human possesses a specific gut microbiota, which can …